Amgen, Inc. | Amgen | Maryland | state | 2007 | $111,395 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2018 | $111,224 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $110,366 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2011 | $110,254 | | property tax abatement |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2012 | $108,730 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2013 | $108,155 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2010 | $107,498 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2011 | $106,749 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $106,749 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2008 | $106,315 | | tax credit/rebate |
EISAI INC | Eisai | Pennsylvania | state | 2020 | $106,100 | | tax credit/rebate |
McNeil Consumer Healthcare Division of McNEll-PPC, | Johnson & Johnson | Illinois | state | 2013 | $105,502 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2010 | $105,430 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2017 | $104,949 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2019 | $104,551 | | tax credit/rebate |
Astellas Pharma Manufacturing, Inc. | Astellas Pharma | New York | local | 2007 | $103,752 | | tax credit/rebate; property tax abatement |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2004 | $103,579 | | tax credit/rebate |
Emergent Biosolutions Inc. & Subsidiaries | Emergent BioSolutions | Maryland | state | 2012 | $103,503 | | tax credit/rebate |
Emergent Biosolutions Inc. | Emergent BioSolutions | Maryland | state | 2014 | $103,503 | | tax credit/rebate |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2021 | $103,392 | | tax credit/rebate |
Hospira, Inc. | Pfizer | Kansas | state | 2007 | $103,000 | | grant |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2014 | $102,925 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2015 | $102,925 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $102,839 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $102,839 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2016 | $102,839 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2008 | $101,627 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $101,569 | | tax credit/rebate |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2007 | $101,500 | | training reimbursement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $101,286 | | tax credit/rebate; property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2010 | $101,000 | | Enterprise zone |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2007 | $100,927 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2021 | $100,088 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2004 | $100,000 | | tax credit/rebate |
Morphotek, Inc. | Eisai | Pennsylvania | state | | $100,000 | | grant |
CSL Behring LLC | CSL Limited | Pennsylvania | state | | $100,000 | | grant |
BioRexis Pharmaceutical Corporation | Pfizer | Pennsylvania | state | | $100,000 | | grant |
SIGMA-ALDRICH CO. LLC | Merck KGaA (EMD) | Missouri | state | 2011 | $100,000 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | $100,000 | | grant |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2012 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2011 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
AVID Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
AVID Radiopharaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2007 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2006 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2013 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2014 | $100,000 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2015 | $100,000 | | tax credit/rebate |
AMYRIS, INC. | Amyris | California | state | 2012 | $99,927 | | training reimbursement |
Boehringer Ingleheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2010 | $99,643 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2009 | $99,581 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2010 | $99,581 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2020 | $99,157 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2014 | $98,490 | | tax credit/rebate |
Albany Molecular | Curia Inc. | New York | local | 2014 | $98,411 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $98,270 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2012 | $98,234 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2012 | $98,209 | | tax credit/rebate |
Boehringer Ingelheim USA Corporation | Boehringer Ingelheim | Connecticut | state | 2012 | $98,000 | | tax credit/rebate |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2011 | $97,908 | | property tax abatement |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2009 | $97,635 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $97,337 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $97,120 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2010 | $97,100 | | tax credit/rebate |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2008 | $96,916 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $96,902 | | tax credit/rebate |
PBM Nutritionals | Perrigo | Vermont | state | 2010 | $96,617 | | training reimbursement |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2010 | $96,488 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2012 | $96,303 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Pennsylvania | state | 2020 | $96,100 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2002 | $95,858 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $95,771 | | enterprise zone |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2020 | $95,736 | | training reimbursement |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2010 | $95,385 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2007 | $94,861 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2017 | $93,554 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2011 | $93,540 | | tax credit/rebate |
Otsuka American Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2007 | $92,420 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2018 | $92,289 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2020 | $92,287 | | tax credit/rebate |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2012 | $92,277 | | enterprise zone |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2018 | $92,193 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2011 | $91,754 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2010 | $91,754 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2015 | $91,536 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $91,500 | | tax credit/rebate |
Synthes North America, Inc. | Johnson & Johnson | Pennsylvania | state | 2008 | $90,887 | | tax credit/rebate |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2012 | $90,531 | | property tax abatement |
Forest Laboratories, Inc. | AbbVie | New York | local | 2014 | $90,408 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2012 | $90,160 | | property tax abatement |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2015 | $89,958 | | tax credit/rebate |
Merck & Co., Inc. | Merck | Virginia | state | 2010 | $89,383 | | training reimbursement |
Mylan Pharmaceuticals Inc. | Viatris | West Virginia | state | 2010 | $88,600 | | training reimbursement |
Amgen Inc. | Amgen | Maryland | state | 2004 | $88,478 | | tax credit/rebate |